Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Novo Nordisk gets FDA okay for new diabetes hope

Novo Nordisk gets FDA okay for new diabetes hope

Sales of Victoza fell 5% in the first half of the year to around $1.6bn, and while the decline was more than offset by growth by Ozempic’s $550m contribution ... to Reuters, and that would make it a larger product than Victoza at its peak.

Novo Nordisk shareholder revolt reaches Europe

Novo Nordisk shareholder revolt reaches Europe Novo Nordisk has latterly become less reliant on sales of its insulin products as newer products, particularly GLP-1 agonists Victoza (liraglutide) and Ozempic (semaglutide), have increased their share of revenues.

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12% Trulicity's growth to date has stemmed largely from its once-weekly dosing, which proved a popular alternative to daily GLP-1 agonists such as Novo Nordisk's older drug Victoza ... empagliflozin) equivalent to once-daily injectable Victoza at both six-

Novo uses voucher for speedy answer on oral semaglutide

Novo uses voucher for speedy answer on oral semaglutide s own daily GLP-1 injection Victoza (liraglutide), as well as placebo. ... s older daily GLP-1 treatment Victoza as the biggest seller in the category this year.

Trulicity’s ascent lifts Lilly

Trulicity’s ascent lifts Lilly This contributed to a full-year increase of 58% to $3.19bn, bringing it within reach of its main rival, Novo Nordisk’s daily injectable Victoza, which earned 3.7bn last

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics